Correlation Between Dr Reddys and Pacira Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Dr Reddys and Pacira Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dr Reddys and Pacira Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Dr Reddys Laboratories and Pacira Pharmaceuticals, you can compare the effects of market volatilities on Dr Reddys and Pacira Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dr Reddys with a short position of Pacira Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dr Reddys and Pacira Pharmaceuticals.

Diversification Opportunities for Dr Reddys and Pacira Pharmaceuticals

0.57

Correlation Coefficient

Dr Reddys  Pacira Pharmaceuticals

Very weak diversification

The 3 months correlation between RDY and Pacira is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding Dr Reddys Laboratories and Pacira Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pacira Pharmaceuticals and Dr Reddys is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dr Reddys Laboratories are associated (or correlated) with Pacira Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pacira Pharmaceuticals has no effect on the direction of Dr Reddys i.e., Dr Reddys and Pacira Pharmaceuticals go up and down completely randomly.

Pair Corralation between Dr Reddys and Pacira Pharmaceuticals

Considering the 90-day investment horizon Dr Reddys Laboratories is expected to generate 0.9 times more return on investment than Pacira Pharmaceuticals. However, Dr Reddys Laboratories is 1.11 times less risky than Pacira Pharmaceuticals. It trades about -0.08 of its potential returns per unit of risk. Pacira Pharmaceuticals is currently generating about -0.17 per unit of risk. If you would invest  7,370  in Dr Reddys Laboratories on February 8, 2024 and sell it today you would lose (236.00) from holding Dr Reddys Laboratories or give up 3.2% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Dr Reddys Laboratories  vs.  Pacira Pharmaceuticals

Dr Reddys Laboratories

Risk-Adjusted Performance

0 of 100

Insignificant

Over the last 90 days Dr Reddys Laboratories has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong fundamental indicators, Dr Reddys is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Pacira Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Pacira Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Pacira Pharmaceuticals is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Dr Reddys and Pacira Pharmaceuticals

The main advantage of trading using opposite Dr Reddys and Pacira Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dr Reddys position performs unexpectedly, Pacira Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pacira Pharmaceuticals will offset losses from the drop in Pacira Pharmaceuticals' long position.

The idea behind Dr Reddys Laboratories and Pacira Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.